Exagen Inc. (NASDAQ: XGN) Stock Information | RedChip

Exagen Inc. (NASDAQ: XGN) Listen to this Section


$3.12
+0.2900 ( +10.25% ) 143.4K

Exagen Inc is a commercial-stage diagnostics company committed to addressing the unmet need for the accurate diagnosis and monitoring of patients affected by autoimmune rheumatic diseases. It currently markets ten testing products under its Avise brand to provide an accurate, timely, and differential diagnosis and to optimize the treatment of ARDs. It markets and sells solutions to community rheumatologists.

Market Data


Open


$3.12

Previous close


$2.83

Volume


143.4K

Market cap


$54.59M

Day range


$2.64 - $3.21

52 week range


$1.30 - $3.71

Insider Ownership Transactions

Total Amount Purchased: -50,360.00 | $ -157,123.20

Date Type Amount Purchased Purchaser
2024-02-08 Sale -6738.00 Adawi Kamal
2023-10-18 Sale -33819.00 ABALLI JOHN
2023-09-06 Sale -9803.00 ABALLI JOHN

SEC Fillings


Form Type Description Pages Date
8-k 8K-related 13 Jun 11, 2024
4 Insider transactions 1 May 16, 2024
10-q Quarterly Reports 61 May 13, 2024
8-k 8K-related 15 May 13, 2024
def Proxies and info statements 4 Apr 26, 2024
8-k 8K-related 14 Apr 26, 2024
ars Annual reports 1 Apr 26, 2024
8-k 8K-related 15 Mar 18, 2024
10-k Annual reports 82 Mar 18, 2024
4 Insider transactions 1 Mar 06, 2024

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.